Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

HZNP Horizon Therapeutics

Watchlist
109.680
-0.110-0.10%
Close  02/03 16:00 ET
109.6800.0000.00%
Post Mkt Price 02/03 16:15 ET
High
110.260
Open
109.750
Turnover
248.38M
Low
109.550
Pre Close
109.790
Volume
2.26M
Market Cap
24.86B
P/E(TTM)
45.14
52wk High
117.490
Shares
226.62M
P/E(Static)
48.32
52wk Low
57.840
Float Cap
24.60B
Bid/Ask %
-81.82%
Historical High
120.535
Shs Float
224.30M
Volume Ratio
0.49
Historical Low
1.965
Dividend TTM
--
Div Yield TTM
--
P/B
4.94
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.01%
Amplitude
0.65%
Avg Price
109.877
Lot Size
1
Float Cap
24.60B
Bid/Ask %
-81.82%
Historical High
120.535
Shs Float
224.30M
Volume Ratio
0.49
Historical Low
1.965
Dividend TTM
--
P/B
4.94
Dividend LFY
--
Turnover Ratio
1.01%
Amplitude
0.65%
Avg Price
109.877
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.
CEO: Mr. Timothy P. Walbert
Market: NASDAQ
Listing Date: 07/28/2011
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist